Taken into account that the sequences of these synthetic peptides are highly conserved and bind in a promiscuous manner to murine or human MHC molecules according to in silico analysis and structure-based techniques, make them candidate vaccines against leishmaniasis. The gene discussed is HLA-C; the disease is leishmaniasis.